Inspira Technologies Rallies 25% on $22.5M Order for FDA-Cleared Respiratory System
Inspira Technologies OXY B.H.N. Ltd. ( $IINN) surged 25.34% to lead the PRISM Emerging MedDevices Index after securing a binding $22.5 million purchase order for its FDA-cleared ART100 system. The order, placed by a global strategic partner outside the U.S., marks a significant transition into revenue generation for the company. Deployment is already underway, with Inspira emphasizing this milestone as an endorsement of its life-support technology and a catalyst for further international expansion. The ART100 system, designed for use in cardiopulmonary bypass and ECMO procedures, has seen successful clinical use in top-tier U.S. hospitals and will serve as the foundation for broader commercialization of the company's respiratory and blood-monitoring platforms.
Other PRISM Mid-Day Movers:
? Cytosorbents Corporation ( $CTSO) down 25.58%
? Daqo New Energy Corp. ( $DQ) up 18.59%
? Kolibri Global Energy Inc. ( $KGEI) down 18.78%
? Verastem, Inc. ( $VSTM) up 17.02%
The post PRISM Mid-Day Movers: Commercial Momentum for MedDevices Boosts Index appeared first on PRISM MarketView.
COMTEX_466870426/2927/2025-07-02T13:30:43